# | ||||
---|---|---|---|---|
1 | EUCILIA "Pathophysiology of rare diseases due to ciliary dysfunction: nephronophthisis, Oral-facial-digital type 1 and Bardet-Biedl syndromes" | 2008 | 3˙848˙873.00 | 2˙930˙300.00 |
2 | EYE MICRORNAS Study of the functional role of microRNAs in the eye | 2008 | 45˙000.00 | 45˙000.00 |
3 | AAVEYE GENE THERAPY FOR INHERITED SEVERE PHOTORECEPTOR DISEASES | 2008 | 3˙907˙401.00 | 2˙971˙000.00 |
4 | CARDIOGENET Definition of a genetic network involved in congenital heart disease | 2009 | 3˙929˙129.00 | 2˙680˙000.00 |
5 | CLEAR Modulating cellular clearance to cure human disease | 2010 | 2˙100˙000.00 | 2˙100˙000.00 |
6 | TIGRE Targeting glucocorticoid resistance in T-ALL: a Systems Biology approach | 2010 | 232˙902.00 | 232˙902.00 |
7 | RETGENTX Overcoming the challenge of large gene transfer for the therapy of inherited retinal diseases | 2012 | 1˙500˙000.00 | 1˙500˙000.00 |
8 | IEMTX Therapies for inborn errors of metabolism | 2012 | 1˙491˙520.00 | 1˙491˙520.00 |
9 | DTI-IMPORT DULBECCO TELETHON INSTITUTE-INTERNATIONAL MOBILITY FOR POSTDOCTORAL RESEARCH TRAINING | 2012 | 5˙485˙408.00 | 2˙194˙163.00 |
10 | MEUSIX Clinical trial of gene therapy for MPS VI - a severe lysosomal storage disorder | 2012 | 7˙877˙621.00 | 5˙995˙041.00 |
11 | ALLELECHOKER DNA binding proteins for treatment of gain of function mutations | 2013 | 1˙354˙840.00 | 1˙354˙840.00 |
12 | .BLASTED2 Identification of molecular targets for the treatment of the skeletal phenotype in Lysosomal Storage Disorders | 2014 | 100˙000.00 | 100˙000.00 |
L'Ente fondazione telethon partecipato anche in questi progetti.